It is a buy of you want in at the bottom and are willing to be patient.
You will never know for sure when it will start climbing, so if you miss the bottom you pay more.
If you wait thinking it will go lower you might lose the opportunity.
Today things studdered waiting for the news from the Jobs report and the FED.
Did you notice once it was announced that that the economic indicators were better than expected and the Fed effectively pushed back tapering there was a large volume and the PPS shot back up within a minute.
There was a period of ten minutes where the bid and the ask stayed the same just before the announcement. That was when it dopped to .4150 only to jump back up to .4299 in a flurry of buys at the ask. Today is Friday, so it will probably close down a tiny bit from the open, but Monday could see it closer .4400.
No way to know other than to say that .41 has been a rock solid bottom forever. Today very well have been the only chance to get in at .42, or less.
The reason the spread has been so large and buys are sporadic is few people will sell at these prices. The shorts keep trying, but they could not break the bottom. Notice the numerous large 40k to 80k share orders which keep the daily volume up. All bought at the higher price ASK. Plenty of 15k order too today.
Noone is selling real shares. It is all shorts which will have to be bought back up to cover.
At the opening bell this morning Interactive Brokers listed only 50,000 shares as shortable. Less than an hour later the amount of available shares to short jumped up to 550,000 shares shortable. Pretty telling.
Actually MSTX trades on the AMEX and if you read their rules MSTX is years away from being worried about a delisting. Sometime in 2016 they may have to dillute to raise cash in order to remain listed, but the only way they would be delisted is if they were not able to raise cash when they use the ATM in late 2016.
I saw the announcement on Mast Therapuetics FaceBook page.
This could result in an analyst upgrade to strong buy.
Tenthoff is Jaffrey's leady Biotech Analyst.
Not sure how, or where to listen to it, or even if it is being broadcast.
My comment was based on the verbatum explanation given during the conference. You can speculate the malingering issue, but I doubt it. Someone suffering from this serious of a disiese will not have a problem getting a regular take home prescription of narcotic pain medication on an outpatient basis. They would have no need to stay in the hospital pretending to be in pain to get hydrocodone.
Not at all. The Phase III study is to prove that the MST-188 therapy reduces the average 4 day crisis event by at least 16 hours which is what their consult with the FDA came up with that they would need for approval. They already know it will, but they have to do the study because in the last trial that was done with MST-188 even though the patients receiving MST-188 were recovering from the crisis event much sooner it was discontinued due to 10% of the patients suffering renal toxicity.
The presentation they gave yesterday was impressive and we KNOW investors were there listening in.
The zero % toxicity with the new manufacturing process was great to hear.
The other interesting fact I discerned was that MST-188 works just as well in adults as it does in children. I had thought the EPIC study foicusing on children implied effacy was not as good in adults, but I was wrong. The ONLY reason the EPIC study is just focusing on children is because parents tend to get their kids to the hospital much sooner than an adult patient checks themself in. Adults are more prone to put off going to the hospital hoping that it will clear up which means the study would have far less time to gauge therapuetic benefit since an adult participation in the study scews the results by prolonging the period of time before a patent is treated after the onset.
The "THEY" are the HFT Traders. Most of whom short their own stocks, so what they do is virtually free of risk..They trade inhouse and don't have to pay broker fees.
1.2 million shares combined traded in Aftermarket and premarket on the news. Then 3.3 million shares traded hands this morning at .46 on up. Another million has traded since it went back down and is on the buy side ask.
Remember the golden rule.VOLUME before PRICE.
I wholeheartedly believe we will see a steady climb similar to what that Zack's analyst is concluding.
This morning was the pop for those wanting a quick buck that bought at .43-.44 and some of the shorts that wanted out.
Getting the orphan drug status will make a difference. The bottom is in with a reenforced foundation..
Only way to go is up.
News was out last night. There was a lot of people trading in After Hours.
Many people are taking the quick profit.
I think we will see it close up after the dust settles today.
$heff sold his shares to break even and his people dumped with him this morning.
$heff had taken som major losses these past two weeks and probably needed cash.
Let the scramble clear. Plenty of time to see it climb.
Might be steady over a two week period.
I think I know what happened this morning.
$heff took some seriously big losses these past two weeks
He sold his MSTX shares this morning just to break even, so many of his people sold with him.